Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Cylexin phase II results announced

May 10, 1996

Zynaxis to develop Zyn-Linker form of paclitaxel for restenosis Rx

May 10, 1996

Cardioprotective activity of LU-51198 demonstrated in animal model

May 10, 1996

5-HT2 antagonists claimed by Toa Eiyo

May 10, 1996

Napp introduces novel diltiazem formulation in U.K.

May 10, 1996

New antihypertensive/diuretic isolated from natural source

May 10, 1996

PD-161721: A new tool for the study of ET receptors

May 10, 1996

LU-135252 improves pulmonary hypertension in rats

May 10, 1996

Endothelin antagonists reported by Bristol-Myers Squibb

May 10, 1996

Ciba-Geigy reveals renin inhibitors

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...